Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-09-18
DOI
10.1080/14740338.2018.1524869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
- (2018) Davide Capodanno et al. Nature Reviews Cardiology
- Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
- (2018) Kajetan Grodecki et al. THROMBOSIS RESEARCH
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction
- (2018) Otavio Berwanger et al. JAMA Cardiology
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities
- (2017) Davide Capodanno et al. JACC-Cardiovascular Interventions
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gender differences in cardiovascular prophylaxis: Focus on antiplatelet treatment
- (2017) Paolo Di Giosia et al. PHARMACOLOGICAL RESEARCH
- Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
- (2016) Usman Baber et al. AMERICAN HEART JOURNAL
- Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2016) Janelle M. Guirguis-Blake et al. ANNALS OF INTERNAL MEDICINE
- Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2016) Dominick J. Angiolillo et al. Circulation-Cardiovascular Interventions
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents
- (2016) Jennifer Yu et al. JACC-Cardiovascular Interventions
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gender Differences in Cardiovascular Drugs
- (2015) Amanda J. Stolarz et al. CARDIOVASCULAR DRUGS AND THERAPY
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
- (2015) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation
- (2015) M. Haim et al. Journal of the American Heart Association
- Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions
- (2014) Davide Capodanno et al. Circulation-Cardiovascular Interventions
- The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial
- (2014) S. Husted et al. EUROPEAN HEART JOURNAL
- A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention
- (2014) Sunil V. Rao et al. JACC-Cardiovascular Interventions
- Sex‐Based Differences in Outcomes After Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report From TRANSLATE‐ACS
- (2014) Connie N. Hess et al. Journal of the American Heart Association
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- An Updated Bleeding Model to Predict the Risk of Post-Procedure Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
- (2013) Sunil V. Rao et al. JACC-Cardiovascular Interventions
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke)
- (2012) Sidney C. Smith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
- (2012) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- A Tale of Coronary Artery Disease and Myocardial Infarction
- (2012) Elizabeth G. Nabel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban: A New Oral Factor Xa Inhibitor
- (2010) Elisabeth Perzborn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Basic Principles of Platelet Biology and Clinical Implications
- (2010) Dominick J. Angiolillo et al. CIRCULATION JOURNAL
- A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
- (2010) Roxana Mehran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of race and gender on antithrombotic therapy
- (2010) Davide Capodanno et al. THROMBOSIS AND HAEMOSTASIS
- Protease-activated receptors in cardiovascular health and diseases
- (2009) Rahman Shah AMERICAN HEART JOURNAL
- Status of Women in Cardiovascular Clinical Trials
- (2009) Esther S.H. Kim et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Relative Efficacy and Safety of Clopidogrel in Women and Men
- (2009) Jeffrey S. Berger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Gender differences in risk factors for coronary heart disease
- (2009) Yen Y. Tan et al. MATURITAS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid
- (2008) John W. Eikelboom et al. CIRCULATION
- Risk factors for myocardial infarction in women and men: insights from the INTERHEART study
- (2008) Sonia S. Anand et al. EUROPEAN HEART JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now